Nordic Capital builds on its existing Healthcare sector track record with further expansion into US market
June 17 2019
– and announces latest investment in US-based provider of life sciences software
The Advisor to the Nordic Capital Funds announces its further expansion into the US, building on Nordic Capital’s reputation as a leading investor in global healthcare and already established track record in the US market. After ten years of Nordic Capital successfully investing in the US healthcare space, the Advisor to the Nordic Capital Funds will open new offices in New York during the Autumn of 2019. The initiative is led by Dr Raj Shah M.D, Partner and Co-Head of Healthcare. Thomas Vetander, Partner and an experienced member of the Healthcare team will relocate from Stockholm to New York later this year.
Nordic Capital is one of the most active and experienced investors in healthcare globally and enjoys a long track-record of investing in US-based healthcare companies and building industry leaders. Since inception in 1989, Nordic Capital has invested over EUR 5.4 billion in healthcare companies, of which c. EUR 1.4 billion has been invested into US-based healthcare companies.
Dr Raj Shah M.D, Partner at the Advisor to the Nordic Capital Funds, said: “The US is a key global market for healthcare companies and offers opportunities that are consistent with Nordic Capital’s healthcare investment strategy for both new investments as well as existing portfolio companies. Nordic Capital has been investing in the US healthcare market for many years and establishing an advisory office in the US for healthcare is a natural evolution. We look forward to building on Nordic Capital’s thirty-year track record in global healthcare investment.”
Thomas Vetander, Partner at the Advisor to the Nordic Capital Funds, added: “Nordic Capital favours segments that are well placed to achieve long term growth driven by favourable sector trends such as changing population demographics, continued technological and scientific innovation, and public and private cost pressures. Nordic Capital looks to partner with businesses where it can bring a powerful combination of capital and strong operational skills to accelerate growth and support positive transformative change.”
Nordic Capital Fund IX’s latest investment is US-based ArisGlobal, a leading global provider of life sciences software that is transforming the way today’s most successful life sciences companies develop medical breakthroughs and bring new drugs to market. In January 2019 Nordic Capital Fund IX acquired Orchid Orthopedic Solutions, a world leader in design and manufacture of orthopaedic implants based in Holt, Michigan. Another US based portfolio company is ERT, a Nordic Capital Fund VIII investment, which is a Pennsylvania-based data and technology company offering solutions to minimise risk and uncertainty for its customers’ clinical trials.
To date, Nordic Capital has invested a total of EUR 14 billion, of which approx. 40% has been deployed in healthcare globally.
Footnote: “Nordic Capital” or the “Nordic Capital Funds” refers to any, or all, Nordic Capital branded or associated funds or investment vehicles and their respective management entities. Nordic Capital is advised by its exclusive advisors, the NC Advisory entities and the Nordic Capital Investment Advisory entities, any or all of which is referred to as the Advisor to the Nordic Capital Funds.
Katarina Janerud, Communications Manager
Advisor to the Nordic Capital Funds
Tel: +46 8 440 50 50
About Nordic Capital
Nordic Capital is a leading private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a proven track record. Core sectors are Healthcare, Technology & Payments, Financial Services and in addition, Industrial Goods & Services and Consumer. Key regions are the Nordics, Northern Europe and globally for Healthcare. Since inception in 1989, Nordic Capital has invested EUR 14 billion in over 100 investments. The most recent fund is Nordic Capital Fund IX with EUR 4.3 billion in committed capital, principally provided by international institutional investors such as pension funds. The Nordic Capital Funds and vehicles are based in Jersey. They are advised by several advisory entities, which are based in Sweden, Denmark, Finland, Norway, Germany, the UK and the US, any or all of which is referred to as the Advisor to the Nordic Capital Funds. For further information about Nordic Capital, please visit www.nordiccapital.com